Related references
Note: Only part of the references are listed.Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study
J. Stafford et al.
PSYCHOLOGICAL MEDICINE (2023)
A Longitudinal Analysis of Reflective Functioning and Its Association With Psychotherapy Outcome in Patients With Depressive and Anxiety Disorders
Anna Babl et al.
JOURNAL OF COUNSELING PSYCHOLOGY (2022)
Markers of Schizophrenia-A Critical Narrative Update
Beata Galinska-Skok et al.
JOURNAL OF CLINICAL MEDICINE (2022)
History of the dopamine hypothesis of antipsychotic action
Mary Seeman
WORLD JOURNAL OF PSYCHIATRY (2021)
Cognitive impairment and development of dementia in very late-onset schizophrenia-like psychosis: a systematic review
Victoria X. Yang et al.
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2021)
A Case for Thalamic Mechanisms of Schizophrenia: Perspective From Modeling 22q11.2 Deletion Syndrome
Yanbo Jiang et al.
FRONTIERS IN NEURAL CIRCUITS (2021)
Specific features of rational pharmacotherapy in elderly patients
Dmitriy Ermakov et al.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2021)
Etiopathogenesis of schizophrenia - the state of the art for 2021
Janusz Rybakowski
PSYCHIATRIA POLSKA (2021)
Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia
Qiongqiong Wu et al.
NEUROSCIENCE BULLETIN (2021)
EPA guidance on treatment of negative symptoms in schizophrenia
S. Galderisi et al.
EUROPEAN PSYCHIATRY (2021)
Investigation of risk of dementia diagnosis and death in patients in older people's secondary care mental health services
Anne Kershenbaum et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2021)
Sertraline treatment decreased the serum levels of interleukin-6 and high-sensitivity C-reactive protein in hematopoietic stem cell transplantation patients with depression; a randomized double-blind, placebo-controlled clinical trial
Maria Tavakoli Ardakani et al.
BONE MARROW TRANSPLANTATION (2020)
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice
Stefania Tognin et al.
SCHIZOPHRENIA BULLETIN (2020)
Ranking Antipsychotics for Efficacy and Safety in Schizophrenia
Christoph U. Correll et al.
JAMA PSYCHIATRY (2020)
Vitamin-D and COVID-19: do deficient risk a poorer outcome?
Fiona Mitchell
LANCET DIABETES & ENDOCRINOLOGY (2020)
A neuroimaging biomarker for striatal dysfunction in schizophrenia
Ang Li et al.
NATURE MEDICINE (2020)
Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease
Madis Parksepp et al.
SCIENTIFIC REPORTS (2020)
Correlations between age, biomedical variables, and cognition in patients with schizophrenia
Wei Tang et al.
SCHIZOPHRENIA RESEARCH-COGNITION (2020)
The Psychotherapeutic Treatment of Schizophrenia: Psychoanalytical Explorations of the Metacognitive Movement
Ondrej Pec et al.
JOURNAL OF CONTEMPORARY PSYCHOTHERAPY (2020)
Risk of dementia associated with psychotic disorders in later life: the health in men study (HIMS)
Osvaldo P. Almeida et al.
PSYCHOLOGICAL MEDICINE (2019)
Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia
Leslie G. Nucifora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Connectal coding: discovering the structures linking cognitive phenotypes to individual histories
Joshua T. Vogelstein et al.
CURRENT OPINION IN NEUROBIOLOGY (2019)
The Incidence of Nonaffective, Nonorganic Psychotic Disorders in Older People: A Population-based Cohort Study of 3 Million People in Sweden
Jean Stafford et al.
SCHIZOPHRENIA BULLETIN (2019)
Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort
Yoonho Chung et al.
NEUROIMAGE-CLINICAL (2019)
Metacognitively oriented psychotherapy for schizotypal personality disorder: A two-case series
Simone Cheli et al.
PERSONALITY AND MENTAL HEALTH (2019)
Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis
Marc Krause et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Psychiatry's contribution to the public stereotype of schizophrenia: Historical considerations
Heinz Katschnig
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2018)
A systematic review of metabolite biomarkers of schizophrenia
Jennifer Davison et al.
SCHIZOPHRENIA RESEARCH (2018)
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
Zachary Munn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine
Domenico De Berardis et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
Psychotherapy in Psychosis: Experiences of Fully Recovered Service Users
Jone Bjornestad et al.
FRONTIERS IN PSYCHOLOGY (2018)
Individual prediction of long-term outcome in adolescents at ultra-high risk for psychosis: Applying machine learning techniques to brain imaging data
Sanne de Wit et al.
HUMAN BRAIN MAPPING (2017)
Brain-derived neurotrophic factor in mood disorders and antidepressant treatments
Eero Castren et al.
NEUROBIOLOGY OF DISEASE (2017)
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
Christoph U. Correll et al.
WORLD PSYCHIATRY (2017)
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis
Carsten Hjorthoj et al.
LANCET PSYCHIATRY (2017)
Accelerated Gray and White Matter Deterioration With Age in Schizophrenia
Vanessa L. Cropley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Psychotherapy Techniques for Patients Diagnosed with Schizophrenia
Andrew C. Lotterman
AMERICAN JOURNAL OF PSYCHOTHERAPY (2016)
The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology
Sun-Young Ahn et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2015)
Detecting Neuroimaging Biomarkers for Schizophrenia: A Meta-Analysis of Multivariate Pattern Recognition Studies
Joseph Kambeitz et al.
NEUROPSYCHOPHARMACOLOGY (2015)
The effectiveness of psychodynamic psychotherapies: An update
Peter Fonagy
WORLD PSYCHIATRY (2015)
Neurodevelopmental origin of cognitive impairment in schizophrenia
E. Bora
PSYCHOLOGICAL MEDICINE (2015)
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
Maren Carbon et al.
CNS SPECTRUMS (2014)
A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis
Javier Vazquez-Bourgon et al.
PSYCHIATRY INVESTIGATION (2014)
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Edward Chesney et al.
WORLD PSYCHIATRY (2014)
Are There Progressive Brain Changes in Schizophrenia? A Meta-Analysis of Structural Magnetic Resonance Imaging Studies
Bayanne Olabi et al.
BIOLOGICAL PSYCHIATRY (2011)
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Alan H. Nagahara et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder
W. Hennah et al.
MOLECULAR PSYCHIATRY (2009)
The interpretation of systematic reviews with meta-analyses: an objective or subjective process?
Ian Shrier et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2008)
Partial compliance and risk of rehospitalization among California medicaid patients with schizophrenia
PJ Weiden et al.
PSYCHIATRIC SERVICES (2004)
Narrative transformation as an outcome in the psychotherapy of schizophrenia
PH Lysaker et al.
PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE (2003)
Share Paper
